WHITESIDES GEORGE M 4
4 · Lyra Therapeutics, Inc. · Filed May 6, 2020
Insider Transaction Report
Form 4
WHITESIDES GEORGE M
Director
Transactions
- Conversion
Common Stock
2020-05-05+6,404→ 55,064 total - Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−67,672→ 0 total→ Common Stock (1,962 underlying) - Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−97,216→ 0 total→ Common Stock (2,819 underlying) - Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−55,991→ 0 total→ Common Stock (1,623 underlying)
Footnotes (1)
- [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering.